FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Amgen BLA for Migraine Therapy Approved

FDA approves an Amgen BLA for Aimovig (erenumab), a once-monthly self-injection for preventing migraines in adults.

Human Drugs

Draft Guide on Drugs for Cytomegalovirus in Transplantation

FDA publishes a draft guidance on Cytomegalovirus in Transplantation: Developing Drugs to Treat or Prevent Disease.

Medical Devices

Medtronic Recalls MindFrame Capture Device

Medtronic recalls its MindFrame Capture LP revascularization device due to wire material that may break or separate during use.

Human Drugs

FDA Alert on Keytruda and Tecentriq Decreased Survival

FDA issues a safety alert about decreased survival associated with the use of Mercks Keytruda (pembrolizumab) and Genentechs Tecentriq (atezolizumab) ...

FDA General

In Era of Government Cuts, FDA Gets $308 Million Boost

While the Trump Administration sets its sights on slashing spending at various federal agencies, FDA continues to get strong support on Capitol Hill f...

Federal Register

Blood Establishment Software Put Into Class 2

Federal Register final rule: FDA classifies blood establishment computer software and accessories (regulated under product code MMH) into Class 2 (spe...

Human Drugs

Warning on Neural Tube Birth Defects with Tivicay

FDA issues a safety alert about serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies bo...

Federal Register

Panel to Review PneumRx PMA for Elevair Endobronchial Coil System.

Federal Register notice: FDA announces a 6/14 Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee meeting t...

Human Drugs

FDA, HHS Guide on IRB Written Procedures

FDA and HHS Office for Human Research Protections issue a joint guidance on Institutional Review Board (IRB) Written Procedures; Guidance for Institut...

Human Drugs

Lawyers Say Federal Circuit Strattera Decision Missed Mark

Alston Bird attorneys say the Court of Appeals for the Federal Circuit should reverse its decision in an Eli Lilly contributory patent infringement ca...